"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial." Published in Nature Medicine, Accessed on November 13, 2023 at National Center for Biotechnology Information (NCBI)
Factors such as geographic location and pharmacy choice also play a vital role in this variation
Long-Lasting Results Unlike fad diets, Semaglutide supports sustainable weight loss when combined with lifestyle changes
Depending on the individual medicine and its FDA-approved indication, GLP-1 receptor agonists may: Stimulate insulin release when blood glucose is elevated Reduce glucagon secretion Slow stomach emptying Increase feelings of fullness Support lower blood glucose Help some patients reduce body weight Semaglutide is a GLP-1 receptor agonist available in several prescription products
While semaglutide refers to the active ingredient, Ozempic denotes the commercial product designed for a particular therapeutic purpose
At Seacoast Rejuvenation Center, we provide semaglutide GLP-1 as part of a comprehensive approach to weight management
